Oxford Nanopore Technologies Stock Fundamentals
| ONTTF Stock | USD 1.77 0.19 12.03% |
Oxford Nanopore Technologies fundamentals help investors to digest information that contributes to Oxford Nanopore's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Nanopore's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Nanopore pink sheet.
Oxford |
Oxford Nanopore Technologies Company Return On Equity Analysis
Oxford Nanopore's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Oxford Nanopore Return On Equity | -0.28 |
Most of Oxford Nanopore's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Nanopore Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Oxford Nanopore Technologies has a Return On Equity of -0.2843. This is 98.81% lower than that of the Healthcare sector and 99.22% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 8.29% lower than that of the firm.
Oxford Nanopore Tech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oxford Nanopore's current stock value. Our valuation model uses many indicators to compare Oxford Nanopore value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oxford Nanopore competition to find correlations between indicators driving Oxford Nanopore's intrinsic value. More Info.Oxford Nanopore Technologies is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oxford Nanopore's earnings, one of the primary drivers of an investment's value.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Oxford Fundamentals
| Return On Equity | -0.28 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.78) % | |||
| Operating Margin | (0.72) % | |||
| Current Valuation | 1.7 B | |||
| Shares Outstanding | 825.96 M | |||
| Shares Owned By Insiders | 34.06 % | |||
| Shares Owned By Institutions | 40.78 % | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 12.58 X | |||
| Revenue | 133.66 M | |||
| Gross Profit | 73.19 M | |||
| EBITDA | (140.41 M) | |||
| Net Income | (167.61 M) | |||
| Cash And Equivalents | 471.65 M | |||
| Cash Per Share | 0.57 X | |||
| Total Debt | 9.5 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 8.51 X | |||
| Book Value Per Share | 0.88 X | |||
| Cash Flow From Operations | (53.83 M) | |||
| Earnings Per Share | (0.28) X | |||
| Number Of Employees | 900 | |||
| Market Capitalization | 2.3 B | |||
| Total Asset | 841.87 M | |||
| Net Asset | 841.87 M |
About Oxford Nanopore Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Nanopore Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Nanopore using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Nanopore Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom. Oxford Nanopore operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 900 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Nanopore financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Nanopore security.